Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2009
02/25/2009EP0896058B1 Novel semaphorin z and gene encoding the same
02/25/2009EP0871763B1 Method for preparation of type ii collagen
02/25/2009EP0852587B1 Synthetic peptides that inhibit il-6 activity
02/25/2009EP0833912B1 Novel tgf-beta like cytokine
02/25/2009EP0698216B2 Methods of typing hepatitis c virus and reagents for use therein
02/25/2009CN101374950A Improved IL-15 and IL-15R-alpha for expression in mammalian cells
02/25/2009CN101374861A Glycopegylated factor VII and factor VIIa
02/25/2009CN101374860A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
02/25/2009CN101374859A A novel surface exposed haemophilus influenzae protein (protein e; pE)
02/25/2009CN101374858A Polyvalent chimeric OSPC vaccinogen and diagnostic antigen
02/25/2009CN101374536A Formulations of human growth hormone comprising a non-naturally encoded amino acid
02/25/2009CN101374533A Use of selected lactic acid bacteria for reducing infantile colic
02/25/2009CN101372692A Ice flower low temperature stress transcription factor AaCBF gene sequence, and clone and use thereof
02/25/2009CN101372691A Novel gene septin 12 transcript variant 2 expressed specifically in human testis
02/25/2009CN101372512A Anticoagulated blood polypeptides and uses thereof
02/25/2009CN101372511A Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
02/25/2009CN101372510A Calcium ion activated chloride ion channel and use thereof
02/25/2009CN101372509A Tomato yellow leaf curl China virus infected aromatic tobacco isolate coat protein, preparation and use thereof
02/25/2009CN101372500A Extracting method and use of Torulopsis capsulatus allergen
02/25/2009CN101371920A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
02/25/2009CN100464566C Method and equipment of changed digital color image
02/25/2009CN100463967C Testicular carnitine transfer protein and its gene
02/25/2009CN100463962C Phenotypic screen of chimeric proteins
02/25/2009CN100463922C Immunoassays for anti-HCV antibodies
02/25/2009CN100463921C Albumin purifaction
02/25/2009CN100463920C Plant salt-tolerance associated protein and genes encoding same and use thereof
02/25/2009CN100463919C Extracellular antiseptic protein for Bacillus subtilis and its separation and purification method
02/25/2009CN100463918C Novel epidermal growth factor protein and gene, and methods of use therefor
02/25/2009CN100463694C Virus coat protein/receptor chimeras and methods of use
02/24/2009US7495157 Plants and seeds of hybrid corn variety CH434931
02/24/2009US7495156 Plants and seeds of corn variety I059908
02/24/2009US7495151 Protein kinase stress-related proteins and methods of use in plants
02/24/2009US7495150 Method of increasing seed oil content in plants
02/24/2009US7495147 Nucleic acids comprising the neuregulin 1 gene (NRG1); use in diagnosis and treatment of schizophrenia; drug screening
02/24/2009US7495091 Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
02/24/2009US7495090 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
02/24/2009US7495089 Inhibit endothelial cell proliferation, angiogenesis and cause tumor regression; antiproliferative, anticarcinogenic and antitumor agents
02/24/2009US7495087 Using interkeukin mutein as therapeutic in treatment of thrombocytopenia
02/24/2009US7495086 TWEAK receptor
02/24/2009US7495084 Polynucleotides, recombinant vectors and host cells for gene expression; antibody fragments
02/24/2009US7495083 PRO940 antibodies
02/24/2009US7495082 Antibodies to PRO4349 polypeptides
02/24/2009US7495080 Cytokine receptor zcytor17
02/24/2009US7495079 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity
02/24/2009US7495078 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity
02/24/2009US7495077 Homogeneous preparations of IL-28 and IL-29
02/24/2009US7495075 Growth differentiation factor-16
02/24/2009US7495074 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology
02/24/2009US7495073 hepatocellular carcinoma; osteopontin and alpha-fetoprotein
02/24/2009US7495070 Avian pancreatic polypeptide comprising antigenic specificity for use in treatment and prevention of allergies, infection, inflammation, autoimmune and tumor disorders
02/24/2009US7494981 Inhibition of interaction of PSD93 and PSD95 with nNOS and NMDA receptors
02/24/2009US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
02/24/2009US7494977 Polypeptides homologous to VEGF and BMP1
02/24/2009US7494976 Antiinflammatory agents; anticancer agents; cholesterol binding protein
02/24/2009US7494975 A polyanion selected from a heparin, a dextran, a pentosan, resobene, curdian sulfate, or 2-naphthalene sulfonate polymer and a CD4 polypeptide with a beta-hairpin confirmation; blocking HIV interaction with coreceptors
02/24/2009US7494974 deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes
02/24/2009US7494973 Therapeutic fibrin-derived peptides and uses thereof
02/24/2009US7494972 Administering a polypeptide comprising a V-type immunoglobulin domain followed by two C-type domains of soluble human receptor for advanced glycation endproduct (sRAGE) by injection, liposome, mouth, eye, nose or topically
02/24/2009US7494971 Pharmaceutical preparations and medicines capable of generating, and/or containing, thrombin
02/24/2009US7494970 Cell calcification suppressing proteins, and genes of the proteins
02/24/2009US7494969 a plant-derived protein with anti-cancer properties which binds the human growth hormone-releasing hormone (hGHRH). Said protein, which is obtained from the Pilocarpus Heterophyllus plant, is particularly adapted for preparing a medicament that is intended for the treatment of cancers for which growth
02/24/2009US7494810 Method for accessing microbial diversity
02/24/2009US7494808 Methods and interferon deficient substrates for the propagation of viruses
02/24/2009US7494804 Polynucleotide encoding cytokine receptor zcytor17 multimer
02/24/2009US7494798 Polypeptides having cellulose 1,4-beta-cellobiosidase activity
02/24/2009US7494788 Entropic bristle domain sequences and their use in recombinant protein production
02/24/2009US7494785 Recombinant subunit vaccine
02/24/2009US7494777 Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma
02/24/2009US7494767 Assay for TSG101 as inhibitors of HIV production
02/24/2009US7494660 HCV NS3-NS4A protease resistance mutants
02/24/2009US7494658 Papilloma virus truncated L1 protein and fusion protein constructs
02/24/2009US7494656 virus-like particle comprising at least one protein and mutein bound to influenza antigens or epitopes, used for inducing immune responsesv in particular antibody responses and for prevention or treatment of infections, allergies, cancer, drug addiction and poisoning
02/24/2009US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome
02/24/2009US7494653 Inoculating a patient with an effective amount of PcrV antigen; monoclonal antibodies specific for the PcrV antigen
02/24/2009US7494646 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
02/24/2009CA2414978C Preparation of a recombinant protein in a prokaryotic host cell
02/24/2009CA2370372C Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
02/24/2009CA2324380C Assay for the diagnosis of schizophrenia based on a new peptide
02/24/2009CA2322713C Process for the determination of ctp11 and for determining whether a tumor sample has metastatic potential
02/24/2009CA2312943C Constitutive expression of non-infectious hiv-like particles
02/24/2009CA2282746C Prediction of coronary artery disease
02/24/2009CA2272850C Genetic test for equine severe combined immunodeficiency disease
02/24/2009CA2245497C Peptide immunogens for vaccination against and treatment of allergy
02/24/2009CA2194236C Helicobacter proteins and vaccines
02/24/2009CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins
02/24/2009CA2174556C Recombinant p53 adenovirus methods and compositions
02/19/2009WO2009023755A1 Late blight resistance gene from wild potato
02/19/2009WO2009023639A1 Modified peptides having toxin-enhancing effects
02/19/2009WO2009023636A1 Novel insect cadherin fragments
02/19/2009WO2009023457A1 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
02/19/2009WO2009023271A2 Kappa-carrageenase and kappa-carrageenase-containing compositions
02/19/2009WO2009023270A2 Compositions and methods for modifying properties of biologically active polypeptides
02/19/2009WO2009023266A1 Generation of antibodies to cell-surface receptors and cancer-associated proteins including egfr family members
02/19/2009WO2009023184A2 Universal fibronectin type iii binding-domain libraries
02/19/2009WO2009023164A2 Induction of mucosal immunity
02/19/2009WO2009022907A2 A method for identifying, expanding, and removing adult stem cells and cancer stem cells
02/19/2009WO2009022652A1 Lck-derived peptide useful for cancer vaccine therapy on cancer patient who is positive for hla-a3 supertype allele
02/19/2009WO2009022632A1 Novel liver cancer marker
02/19/2009WO2009022340A1 Peptides and pharmaceutical compositions for treating connective tissue
02/19/2009WO2009022339A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair